- Home
- VERI vs ORGO Comparison
VERI vs ORGO Comparison
Compare VERI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERI | ORGO |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.9M | 348.6M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | VERI | ORGO |
|---|---|---|
| Price | $2.28 | $2.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $8.20 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 2.6M | 1.4M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.36 | ★ 1600.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | $92,637,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $30.98 | N/A |
| Revenue Next Year | $4.55 | $26.27 |
| P/E Ratio | ★ N/A | $15.87 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $1.29 | $2.21 |
| 52 Week High | $9.42 | $7.08 |
Technical Indicators
Market Signals| Indicator | VERI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 45.44 |
| Support Level | $2.20 | $2.26 |
| Resistance Level | $3.12 | $2.57 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 53.32 | 65.48 |
Price Performance
Historical ComparisonAbout VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.